From Nasdaq: 2025-04-13 23:37:00

Johnson & Johnson is set to report Q1 earnings on April 15, with estimates of $2.59 per share on $21.6B in sales. Factors influencing performance include growth in key drugs and MedTech segment. With a $363B market cap, JNJ has outperformed the market, showing a 5% increase this year. Historical data shows 60% positive one-day post-earnings returns.

Understanding historical patterns can help traders position themselves before or after earnings release. Trefis High-Quality portfolio offers an alternative for lower volatility. Correlation between 1D, 5D, and 21D returns post-earnings can inform trading strategies. Peer earnings can also influence stock reactions. Trefis RV strategy has outperformed all-cap stocks benchmark.



Read more at Nasdaq: How Will Johnson & Johnson Stock React To Its Upcoming Earnings?